Plain-English translation of NCT07164456 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether involving both a prostate cancer survivor and their family caregiver together in a lifestyle program—focused on eating better and moving more—works better than having only the survivor participate or just providing general health education. The program includes nutrition and physical activity education sessions plus 12 one-on-one health coaching calls delivered by phone or video. Researchers want to see if family involvement helps both survivors and caregivers stick with healthier habits and feel better overall.
Black men face higher rates of prostate cancer and often have less support in managing their health after treatment. This trial is testing whether involving the whole family in lifestyle changes—rather than just the survivor—can help both the survivor and their caregiver stay healthier, recover better, and maintain these good habits long-term.
You likely qualify if…
You likely don't qualify if…
You and your caregiver will be randomly assigned to one of three groups: a family program, a survivor-only program, or a control group. All groups receive nutrition education, physical activity education, and 12 health coaching sessions delivered by phone or video conference—roughly 2 sessions per month. The study lasts several months, with a final follow-up check 6 months after the program ends. You'll be asked about your diet, physical activity, mood, quality of life, and family relationships at different points to see if and how things improve.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States
Sponsor
M.D. Anderson Cancer Center
Enrollment target
~648 participants
Started
January 2026
Primary completion
June 2031
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dalnim Cho, MD
MD Andersson Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.